Paul T. Manser

771 total citations
22 papers, 262 citations indexed

About

Paul T. Manser is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Paul T. Manser has authored 22 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Paul T. Manser's work include Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (10 papers) and Medical Imaging Techniques and Applications (5 papers). Paul T. Manser is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (10 papers) and Medical Imaging Techniques and Applications (5 papers). Paul T. Manser collaborates with scholars based in United States, United Kingdom and Germany. Paul T. Manser's co-authors include Geoffrey A. Kerchner, Robby M. Weimer, Kristin R. Wildsmith, Michael E. Ward, Sandra Sanabria Bohórquez, Edmond Teng, Nina Zhou, Suzanne L. Baker, Gai Ayalon and David Alagille and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Kidney International.

In The Last Decade

Paul T. Manser

19 papers receiving 258 citations

Peers

Countries citing papers authored by Paul T. Manser

Since Specialization

Citations

This map shows the geographic impact of Paul T. Manser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul T. Manser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul T. Manser more than expected).

Fields of papers citing papers by Paul T. Manser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul T. Manser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul T. Manser. The network helps show where Paul T. Manser may publish in the future.

Co-authorship network of co-authors of Paul T. Manser

This figure shows the co-authorship network connecting the top 25 collaborators of Paul T. Manser. A scholar is included among the top collaborators of Paul T. Manser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul T. Manser. Paul T. Manser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY 2025 ·Kidney International Reports ·Uptal D. Patel, (unknown), Jonathan Barratt, Richard Lafayette, Brian S. Schwartz, Paul T. Manser, (unknown), (unknown), (unknown), (unknown), Sean Barbour	0
2	Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy 2025 ·Kidney International ·Jürgen Floege, Richard Lafayette, Jonathan Barratt, Brian S. Schwartz, Paul T. Manser, Uptal D. Patel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sean J. Barbour	1
3	Felzartamab Durably Reduces Disease-Relevant Biomarkers through Targeting of CD38+ Plasma Cells and Plasmablasts, the Upstream Drivers of IgAN 2024 ·Journal of the American Society of Nephrology ·Jonathan Barratt, (unknown), (unknown), (unknown), (unknown), Rainer Boxhammer, (unknown), Brian S. Schwartz, Paul T. Manser, Leslie W. Chinn, Uptal D. Patel, (unknown), Krzysztof Kiryluk	1
4	Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy 2024 ·Kidney International Reports ·Brad H. Rovin, Pierre Ronco, Jack F.M. Wetzels, Sharon G. Adler, Isabelle Ayoub, Philippe Zaoui, Seung Hyeok Han, Jaideep S. Dudani, Houston Gilbert, Uptal D. Patel, Paul T. Manser, (unknown), (unknown), Rainer Boxhammer, (unknown), Ben Sprangers	12
5	Felzartamab for IgA Nephropathy: Final Results of the IGNAZ Study 2024 ·Journal of the American Society of Nephrology ·Jonathan Barratt, Jürgen Floege, Richard Lafayette, (unknown), Uptal D. Patel, Paul T. Manser, (unknown), (unknown), (unknown), (unknown), Sean Barbour	1
6	Evaluation of partial volume correction and analysis of longitudinal [18F]GTP1 tau PET imaging in Alzheimer's disease using linear mixed-effects models 2024 ·SHILAP Revista de lepidopterología ·Sandra Sanabria Bohórquez, Suzanne L. Baker, Paul T. Manser, (unknown), (unknown), Kristin R. Wildsmith, (unknown), Geoffrey A. Kerchner, Robby M. Weimer, Edmond Teng	1
7	Cross‐sectional and longitudinal assessments of function in prodromal‐to‐mild Alzheimer's disease: A comparison of the ADCS‐ADL and A‐IADL‐Q scales 2023 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Edmond Teng, Yihao Li, Paul T. Manser, (unknown), Brandon Butcher, (unknown), Christopher Randolph, Sietske A.M. Sikkes	8
8	Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB 2023 ·CPT Pharmacometrics & Systems Pharmacology ·Samira Jamalian, Michael Dolton, Pascal Chanu, (unknown), (unknown), Kristin R. Wildsmith, Paul T. Manser, Edmond Teng, Jin Y. Jin, Angelica Quartino, (unknown), (unknown)	10
9	In Vivo Head‐To‐Head Comparison of [¹⁸F]GTP1 and [¹⁸F]PI2620 in Alzheimer’s Disease 2022 ·Alzheimer s & Dementia ·Sandra Sanabria Bohórquez, (unknown), Paul T. Manser, Roger N. Gunn, David Russell, (unknown), Santiago Bullich, Andrew Stephens, André Mueller, Gregory Klein, Edmond Teng, (unknown)	1
10	Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease 2021 ·Alzheimer s Research & Therapy ·Edmond Teng, Paul T. Manser, Sandra Sanabria Bohórquez, Kristin R. Wildsmith, (unknown), Suzanne L. Baker, Michael E. Ward, Geoffrey A. Kerchner, Robby M. Weimer	18
11	A comparison of longitudinal [18F]GTP1 tau pet with other imaging and cognitive endpoints in the Tauriel Phase II Study 2021 ·Alzheimer s & Dementia ·Paul T. Manser, Sandra Sanabria Bohórquez, Kristin R. Wildsmith, Balázs István Tóth, (unknown), (unknown), Edmond Teng	1
12	Cognitive indices correlate with [¹⁸F]GTP1 tau PET signal and white matter hyperintensities in prodromal‐to‐mild Alzheimer's disease: Baseline data from the Tauriel Study 2020 ·Alzheimer s & Dementia ·Edmond Teng, Paul T. Manser, (unknown), (unknown), Neha Anegondi, (unknown), Zhuang Song, Richard A.D. Carano, (unknown), Kristin R. Wildsmith, Robby M. Weimer, Sandra Sanabria Bohórquez	0
13	Does including machine learning predictions in ALS clinical trial analysis improve statistical power? 2020 ·Annals of Clinical and Translational Neurology ·Nina Zhou, Paul T. Manser	11
14	Baseline correlations between [¹⁸F]GTP1 PET SUVR and MRI white matter hyperintensities in prodromal‐to‐mild Alzheimer's disease suggest independent contributions to cognitive impairment 2020 ·Alzheimer s & Dementia ·Paul T. Manser, Edmond Teng, (unknown), (unknown), Neha Anegondi, (unknown), Zhuang Song, Richard A.D. Carano, (unknown), Kristin R. Wildsmith, Robby M. Weimer, Sandra Sanabria Bohórquez	0
15	Cross-sectional associations between [18F]GTP1 tau PET and cognition in Alzheimer's disease 2019 ·Neurobiology of Aging ·Edmond Teng, Michael E. Ward, Paul T. Manser, Sandra Sanabria Bohórquez, Rebecca D. Ray, Kristin R. Wildsmith, Suzanne L. Baker, Geoffrey A. Kerchner, Robby M. Weimer	31
16	[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Sandra Sanabria Bohórquez, Jan Mařı́k, Annie Ogasawara, Jeff N. Tinianow, Herman Gill, Olivier Barret, Gilles Tamagnan, David Alagille, Gai Ayalon, Paul T. Manser, Thomas Bengtsson, Michael E. Ward, Simon‐Peter Williams, Geoffrey A. Kerchner, John Seibyl, Kenneth Marek, Robby M. Weimer	82
17	Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology 2019 ·Brain ·Kaj Blennow, Chun Chen, Claudia Cicognola, Kristin R. Wildsmith, Paul T. Manser, (unknown), Zhentao Zhang, Boer Xie, Junmin Peng, Oskar Hansson, Hlin Kvartsberg, Erik Portelius, Henrik Zetterberg, Tammaryn Lashley, Gunnar Brinkmalm, Geoffrey A. Kerchner, Robby M. Weimer, Keqiang Ye, Kina Höglund	66
18	O3‐14‐02: TAU BURDEN MEASURED USING [18F]GTP1 CORRELATES WITH CSF TAU PHOSPHORYLATION AT SITES T217 AND T205 MORE CLOSELY THAN T181 2018 ·Alzheimer s & Dementia ·Kristin R. Wildsmith, Nicolas R. Barthélemy, Sandra Sanabria Bohórquez, Paul T. Manser, Edmond Teng, Michael E. Ward, (unknown), Randall J. Bateman, Robby M. Weimer	2
19	[O2–17–03]: A PHASE I STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF RO7105705 IN HEALTHY VOLUNTEERS AND PATIENTS WITH MILD‐TO‐MODERATE AD 2017 ·Alzheimer s & Dementia ·Geoffrey A. Kerchner, Gai Ayalon, Flávia Brunstein, Priya Chandra, Akash Datwani, Reina N. Fuji, Paul T. Manser, Anjali Vaze, (unknown), Kristin R. Wildsmith, (unknown)	10
20	Equine viral arteritis in a stallion. 2005 ·PubMed ·Paul T. Manser, David G. Westcott	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact